Bioavailability / Bioequivalence / Clinical Trial Studies (BA/BE/CTR)
We also have active association with approved study centers with state of art facilities to perform BA/BE studies (single dose, multiple dose, 2-way, 3-way, replicate design & dose proportionality studies, immediate and modified release, various dosage forms of known molecules) as well as Phase I, II, & III clinical studies (CTR).
Bioequivalence studies is a science based regulatory affairs project which includes a combination of studies based on specialization. The main aim is to establish if rate and extent of absorption of the given sample of the drug is comparable with innovators formulation.
Our Strengths
Tie Up with well established study centers to carry out BA/BE/Clinical Studies.
We add value by
Helping clients carry out BA/BE/CTR studies in well established study centers, which are approved from local DCGI and international WHO, EU, US FDA, Geneva, TGA – Australia, Medsafe – New Zealand and Brazil – ANVISA.
Format And Guideline:- As per country specific guideline.
|